Stay updated on Nivolumab in Relapsed/Refractory DLBCL Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Relapsed/Refractory DLBCL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Relapsed/Refractory DLBCL Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Investigator Inquiry Form was removed from the page. Users can still contact the study team using the listed contacts and locations.
    Difference
    0.0%
    Check dated 2026-08-04T06:45:31.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.4, replacing the previous v3.6.3. This reflects a minor system update to the page rather than a change to the study details.
    Difference
    0.0%
    Check dated 2026-07-28T05:37:58.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The page's revision indicator was bumped from v3.6.2 to v3.6.3, signaling a minor update to the study record.
    Difference
    0.0%
    Check dated 2026-07-06T16:44:52.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Footer revision tag updated from v3.6.0 to v3.6.2, indicating the page has been rebuilt or updated to a newer version.
    Difference
    0.0%
    Check dated 2026-06-29T10:52:09.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The study details page adds a recruitment status indicator stating no participants are being recruited and introduces new guidance sections for reading the study record, common questions, and how to join a study. The Intervention/Treatment label is standardized, and a new site revision tag (v3.6.0) is shown, while the older revision tag is removed.
    Difference
    0.3%
    Check dated 2026-06-14T22:49:29.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.4 to v3.5.5. This indicates a new release of the page metadata rather than changes to study data.
    Difference
    0.0%
    Check dated 2026-06-07T16:00:58.000Z thumbnail image

Stay in the know with updates to Nivolumab in Relapsed/Refractory DLBCL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Relapsed/Refractory DLBCL Clinical Trial page.